Globe Life (GL) Expected to Announce Earnings on Wednesday

Globe Life (NYSE:GL) will likely be posting its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect Globe Life to post earnings of $3.12 per share and revenue of $1.48 billion for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Globe Life Stock Performance

NYSE:GL opened at $122.38 on Tuesday. Globe Life has a fifty-two week low of $38.95 and a fifty-two week high of $132.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The stock’s fifty day moving average is $112.33 and its 200 day moving average is $106.17. The firm has a market capitalization of $10.27 billion, a PE ratio of 10.35 and a beta of 0.81.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date was Monday, January 6th. Globe Life’s payout ratio is 8.12%.

Wall Street Analyst Weigh In

GL has been the topic of a number of recent research reports. Raymond James raised their price objective on Globe Life from $160.00 to $188.00 and gave the company a “strong-buy” rating in a research report on Tuesday, October 15th. Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and increased their price target for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. TD Cowen began coverage on Globe Life in a research note on Wednesday, October 9th. They issued a “buy” rating and a $150.00 price target for the company. Morgan Stanley increased their price target on Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Finally, BMO Capital Markets began coverage on Globe Life in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price target for the company. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus target price of $132.18.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 13,448 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the transaction, the chief executive officer now owns 18,948 shares of the company’s stock, valued at approximately $2,132,786.88. The trade was a 41.51 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Mark A. Blinn sold 3,000 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the transaction, the director now directly owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,788 shares of company stock valued at $4,429,779 over the last ninety days. Insiders own 1.51% of the company’s stock.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.